Increased visceral adipocyte lipolysis--a pathogenic role in nonalcoholic fatty liver disease?
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
CONTEXT: Obesity is a major risk factor for nonalcoholic fatty liver disease, but the primary pathophysiological mechanisms remain unclear. OBJECTIVE: The aim was to study the relative role of visceral and sc in vitro lipolysis for liver fat accumulation. PATIENTS: Eighteen morbidly obese women participated in the study. DESIGN: Hepatic triglyceride accumulation and abdominal visceral and sc fat area were assessed by computer tomography. Biopsies were taken from abdominal sc and visceral fat tissue. Basal and maximal lipolysis was measured using various lipolytic drugs acting at different steps in the lipolytic cascade. RESULTS: No difference in total body, visceral, or sc fat mass was found between patients with high, intermediate, or low amounts of liver fat. In patients with high liver fat content, there was an approximately 2-fold increase in visceral adipocyte maximal glycerol release induced by the different lipolytic agents (P = 0.002 to 0.01). Noradrenaline-mediated free fatty acid release from visceral adipocytes was also about twice as high in patients with high liver fat (P = 0.004). In contrast, in sc adipocytes, no relationship between liver fat content and either glycerol or free fatty acid release was found. CONCLUSIONS: We suggest a pathogenic role of visceral, but not sc, adipocyte lipolytic function in nonalcoholic fatty liver disease, independent of total body fat as well as abdominal fat distribution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“VAT is increased with intrahepatic triglycerides (IHTGs) even in individuals without obesity,11 and is associated with IR11,16.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [16]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
How Useful Is Body Mass Index for Comparison of Body Fatness across Age, Sex, and Ethnic Groups?
Gallagher, D., Visser, M., Sepulveda, D., Pierson, R. N., Harris, T., & Heymsfield, S. B. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008733 · Cited by 1,513
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Kotronen, A., Peltonen, M., Hakkarainen, A., Sevastianova, K., Bergholm, R., Johansson, L. M., Lundbom, N., Rissanen, A., Ridderstråle, M., Groop, L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.005 · Cited by 804
Schwenzer, N. F., Springer, F., Schraml, C., Stefan, N., Machann, J., & Schick, F. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.023 · Cited by 749
Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.038 · Cited by 631
Visceral fat: A key mediator of steatohepatitis in metabolic liver disease†
van der Poorten, D., Milner, K., Hui, J., Hodge, A., Trenell, M. I., Kench, J. G., London, R., Peduto, T., Chisholm, D. J., & George, J. (2008) · Hepatology · doi:10.1002/hep.22350 · Cited by 607
Abdominal Subcutaneous Adipose Tissue: A Protective Fat Depot?
Porter, S. A., Massaro, J. M., Hoffmann, U., Vasan, R. S., O'Donnel, C. J., & Fox, C. S. (2009) · Diabetes Care · doi:10.2337/dc08-2280 · Cited by 487
Thörne, A., Lönnqvist, F., Apelman, J., Hellers, G., & Arner, P. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801871 · Cited by 463
Self-citationHuman fat cell lipolysis: biochemistry, regulation and clinical role.
Arner, P. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.004 · Cited by 401
Cited by
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 529
“Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis
Febbraio, M. A., & Karin, M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.004 · Cited by 173
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
“14,15 VAT is increased with intra-hepatic triglycerides (IHTGs) even in individuals without obesity, 11 and is associated with IR 11,16 .”
Nati, M., Haddad, D., Birkenfeld, A. L., Koch, C. A., Chavakis, T., & Chatzigeorgiou, A. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9339-2 · Cited by 144
Variations in the Size of the Major Omentum Are Primarily Determined by Fat Cell Number
Arner, P., Andersson, D. P., Thörne, A., Wirén, M., Hoffstedt, J., Näslund, E., Thorell, A., & Rydén, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4106 · Cited by 102
Self-citation
Metadata
- Authors
- Thörne, A., Löfgren, P., & Hoffstedt, J.
- Affiliations
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Corresponding author
- Hoffstedt, Johan
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-10
- Volume
- 95
- Issue
- 10
- Pages
- E209-E213
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2094526525
- Cited by
- 25
- References
- 20
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 2
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- non-alcoholic fatty liver disease, visceral adipose tissue, subcutaneous adipose tissue, adipocyte lipolysis, hepatic triglyceride accumulation, obesity, norepinephrine, free fatty acid release, glycerol release, morbid obesity, abdominal fat distribution
- MeSH terms
- Adult, Fatty Liver, Female, Humans, Lipolysis, Middle Aged, Norepinephrine, Obesity, Morbid, Up-Regulation, Adipocytes, Biopsy, Fine-Needle, Subcutaneous Fat, Intra-Abdominal Fat, Body Fat Distribution, Young Adult, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased visceral adipocyte lipolysis--a pathogenic role in nonalcoholic fatty liver disease? https://app.cochat.ai/papers/10.1210/jc.2010-0520
- The paper
- Thörne, A., Löfgren, P., & Hoffstedt, J. (2010). Increased visceral adipocyte lipolysis--a pathogenic role in nonalcoholic fatty liver disease? The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-0520
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.